Right, and I am familiar with some. Which other such deals are you referring to where the big pharma ponies up hundreds of millions in upfront cash for a developmental product that is two years from officially beginning its clinical testing?
Writer on Seeking Alpha covering biotech stocks, particularly in oncology. Ask me anything!